Nanobiotix SA
NBTX
View Detailed Chart
23.040USD
+0.390+1.72%
Close 12/26, 16:00（ET）Quotes delayed by 15 min
1.11BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
+1.72%
5 Days
+4.11%
1 Month
+13.05%
6 Months
+387.10%
Year to Date
+702.79%
1 Year
+673.15%
View Detailed Chart
TradingKey Stock Score of Nanobiotix SA
Currency: USD Updated: 2025-10-27Key Insights
Its valuation is considered fairly valued, Institutional ownership is very high.Over the past month, multiple analysts have rated it as Strong Buy, with the highest price target at max_target_price.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Nanobiotix SA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
7
analysts
Strong Buy
Current Rating
18.067
Target Price
-14.09%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Nanobiotix SA Highlights
StrengthsRisks
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Growing
The company is in a growing phase, with the latest annual income totaling USD -10.69M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD -10.69M.
Undervalued
The company’s latest PE is -10.83, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 5.65M shares, decreasing 42.25% quarter-over-quarter.
Held by Baillie Gifford
Star Investor Baillie Gifford holds 0.00 shares of this stock.
Nanobiotix SA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Nanobiotix SA Info
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
Ticker SymbolNBTX
CompanyNanobiotix SA
CEOLevy (Laurent)
Websitehttps://www.nanobiotix.com
FAQs
What is the current price of Nanobiotix SA (NBTX)?
The current price of Nanobiotix SA (NBTX) is 23.040.
What is the symbol of Nanobiotix SA?
The ticker symbol of Nanobiotix SA is NBTX.
What is the 52-week high of Nanobiotix SA?
The 52-week high of Nanobiotix SA is 30.350.
What is the 52-week low of Nanobiotix SA?
The 52-week low of Nanobiotix SA is 2.820.
What is the market capitalization of Nanobiotix SA?
The market capitalization of Nanobiotix SA is 1.11B.
What is the net income of Nanobiotix SA?
The net income of Nanobiotix SA is -68.13M.
Is Nanobiotix SA (NBTX) currently rated as Buy, Hold, or Sell?
According to analysts, Nanobiotix SA (NBTX) has an overall rating of --, with a price target of 18.067.
What is the Earnings Per Share (EPS TTM) of Nanobiotix SA (NBTX)?
The Earnings Per Share (EPS TTM) of Nanobiotix SA (NBTX) is -1.392.
Related Instruments
+0.05%
-0.07%
+0.08%
+0.49%
+0.23%
+0.38%
-0.31%
-0.30%
-0.77%
+0.30%
+0.23%
-0.02%
-0.07%
+0.24%
+0.26%
+0.30%
+0.16%
0.00%
+0.58%
-0.02%
